| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $861K | -95.4% |
| R&D Expense | $57.9M | +1.1% |
| SG&A Expense | $38.1M | +79.3% |
| Operating Income | -$115.6M | -92.7% |
| Pre-tax Income | -$114.6M | -97.1% |
| Income Tax | $0 | — |
| Net Income | -$114.6M | -97.1% |
| EPS (Basic) | -$2.40 | -62.2% |
| EPS (Diluted) | -$2.40 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.0M | -46.8% |
| Accounts Receivable | $144K | -70.9% |
| Current Assets | $74.6M | -47.7% |
| Total Assets | $162.9M | -27.7% |
| Current Liabilities | $14.7M | -0.7% |
| Long-term Debt | $15.0M | — |
| Total Liabilities | $67.2M | +190.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.9M | -11.5% |
| Capital Expenditures | $2.2M | -86.3% |
| Investing Cash Flow | -$2.2M | +86.3% |
| Financing Cash Flow | $14.9M | -87.5% |
| Free Cash Flow | -$77.0M | +7.3% |
| -62.2% |
| Stockholders' Equity |
| $95.7M |
| -52.7% |